Alambic Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,700
Closed -$697K 508
2017
Q4
$697K Sell
15,700
-1,550
-9% -$70.6K 0.08% 282
2017
Q3
$864K Sell
17,250
-48,190
-74% -$2.46M 0.09% 294
2017
Q2
$3.46M Sell
65,440
-23,160
-26% -$1.24M 0.42% 61
2017
Q1
$4.92M Buy
88,600
+39,260
+80% +$2.17M 0.61% 20
2016
Q4
$2.57M Buy
49,340
+14,130
+40% +$682K 0.46% 47
2016
Q3
$1.7M Sell
35,210
-470
-1% -$23.8K 0.4% 65
2016
Q2
$1.98M Sell
35,680
-1,130
-3% -$62.2K 0.5% 37
2016
Q1
$1.97M Buy
36,810
+10,390
+39% +$512K 0.64% 19
2015
Q4
$1.36M Buy
+26,420
New +$1.31M 0.82% 10

Other funds holding PBH

Alambic Investment Management's PBH Position: Q1 2018 in Review

Alambic Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2018, closing a stake of 15,700 shares — an estimated $697K sold.

Alambic Investment Management first reported a position in PBH in Q4 2015 and held it in 9 quarters. The position peaked at $4.92M in Q1 2017. 239 funds tracked by Wall St. Rank hold PBH as of Q1 2018.

  • Alambic Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2018 after selling out during the quarter.
  • Alambic Investment Management sold 15,700 Prestige Consumer Healthcare shares in Q1 2018, an estimated $697K.
  • Alambic Investment Management first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 9 quarters.
  • Alambic Investment Management's Prestige Consumer Healthcare position peaked at $4.92M in Q1 2017.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2018.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.